Ablation Devices Market by Technology and Non-Thermal Ablation, Application, Function and Procedure - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ID: 3976194
  • Report
  • Region: Global
  • 204 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • AngioDynamics Inc
  • AtriCure Inc
  • BTG plc
  • Conmed Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • MORE
Ablation Devices Market by Technology (Thermal (Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation) and Non-Thermal Ablation (Cryoablation and Hydromechanical Ablation)), Application (Cancer, Cardiovascular, Ophthalmology, Gynecology, Urology, and Orthopedics), Function (Automated/Robotic and Conventional Ablation Devices), and Procedure (Aesthetics-Skin Rejuvenation and Tightening, Aesthetics-Body Sculpting, Fat Reduction, and the Reduction in the Appearance of Cellulite, Benign Prostatic Hyperplasia, Transurethral Needle Ablation, Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation of the Prostate, Stress Urinary Incontinence, Menorrhagia/Endometrial Ablation, Uterine Fibroids, Spinal Decompression and Denervation, Varicose Veins, Atrial Fibrillation and Tumor Ablation) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ablation is a minimal invasive medical procedure to destroy the abnormal tissues. It is performed with the help of probes that can be inserted through the skin or by using catheters that can be inserted through an artery or energy beams to reach the area that needs to be treated. An imaging technique such as MRI or rotational angiography is used to guide the probes or catheters to the site during ablation.

The world ablation device market is estimated to grow from $3,047 million in 2015 to $6,658 million by 2022 at a CAGR of 11.7% from 2016 to 2022. This can be attributed to the increase in demand for minimal invasive surgeries and increase in the prevalence of patients with chronic illnesses. Other factors such as minimal damage and blood loss, and short duration are some of the factors that contribute towards the growth of this market. However, stringent government regulations and unstable reimbursement policies restrain the market growth.

By technology, the ablation devices market is broadly categorized into thermal and non-thermal technologies. Thermal technologies comprise microwave, electrical, light, radiation, ultrasound, radiofrequency, and hydrothermal technologies, and each of these are further subcategorized. Thus, electrical ablation includes electrical ablators and electronic brachytherapy, while light ablation includes cold and exicmer laser. In addition, radiation ablation is sub-categorized into brachytherapy, stereotactic radiotherapy & radiosurgery, stereotactic body radiation, image guided radiation therapy, intensity modulated radiation therapy, and proton beam therapy. While ultrasound ablation is sub-divided into high intensity focused ultrasound (HIFU), magnetic resonance imaging-guided focused ultrasound (MRI-FUS), ultrasonic surgical systems, and shock wave lithotripsy; radiofrequency ablation is sub-divided into temperature controlled, fluid cooled, and catheter manipulation systems. However, the non-thermal technology market comprises cryoablation and hydromechanical ablation, wherein Cryoablation includes tissue contact probe, cryogen spray probe, and epidermal & subcutaneous cryoablation devices.

By applications, the ablation devices market is segmented into cancer, cardiology, ophthalmology, gynecology, urology, orthopedics, and other medical conditions. On the basis of function, the market is divided into automated/robotic and conventional ablation devices. Based on procedure, the market is segmented as aesthetics-skin rejuvenation & tightening, aesthetics-body sculpting, fat reduction, and the reduction in the appearance of cellulite, benign prostatic hyperplasia, transurethral needle ablation, laser- and other energy-based therapies/ holmium laser ablation/enucleation of the prostate, stress urinary incontinence, menorrhagia/endometrial ablation, uterine fibroids, spinal decompression & denervation, varicose veins, atrial fibrillation, tumor ablation, and others. By geography, the ablation devices market is categorized into North America, Europe, Asia-Pacific, and LAMEA.

The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players. For instance, on 26th January 2016, Medtronic PLC acquired Covidien to expand their access and improve their clinical outcomes at lower cost. Moreover, this acquisition has helped Medtronic PLC to compete with Johnson & Johnson. Boston Scientific Corporation acquired Cosman Medical on July 27, 2016to improve its neuromodulation portfolio and help provide innovative solutions for chronic pain treatment.

KEY MARKET BENEFITS:

Quantitative analysis of the current trends and market estimations from 2014 to 2022 is presented to identify potential market opportunities.
The report provides an in-depth analysis of the market and total revenue generated during the forecast period.
A detailed analysis based on applications and procedures are presented to understand the type of products in trend or would be in demand to assist in product developments and collaborations.
Comprehensive analysis of the market drivers and constraints is provided to identify the prevailing market opportunities.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.

KEY MARKET SEGMENTS:

The world ablation devices market segmentation is explained below.

By Technology

Thermal Ablation
Electrical
Electrical Ablators
Argon Plasma/Beam Coagulator
Irreversible Electroporation
Electronic Brachytherapy
Radiation
Brachytherapy
High-Dose-Rate Brachytherapy
Pulsed-Dose-Rate Brachytherapy
Permanent Seed Brachytherapy
Stereotactic Radiotherapy & Radiosurgery
Stereotactic Body Radiation
Image Guided Radiation Therapy
Intensity Modulated Radiation Therapy
Proton Beam Therapy
Radiofrequency
Temperature Controlled
Fluid Cooled
Catheter Manipulation Systems
Light
Cold Lasers
Excimer Lasers
Ultrasound
High Intensity Focused Ultrasound (HIFU)
Magnetic Resonance Imaging-Guided Focused Ultrasound (MRI-FUS)
Ultrasonic Surgical Systems
Shock Wave Lithotripsy
Microwave
Hydrothermal
Non-Thermal Ablation
Cryoablation
Tissue Contact Probe
Cryogen Spray Probe
Epidermal and Subcutaneous Cryoablation Devices
Hydromechanical Ablation

By Application

Cancer
Cardiovascular
Ophthalmology
Gynecology
Urology
Orthopedics
Others

By Function

Automated/Robotic
Conventional

By Procedure

Aesthetics-Skin Rejuvenation and Tightening
Aesthetics-Body Sculpting, Fat Reduction, And The Reduction in The Appearance of Cellulite
Benign Prostatic Hyperplasia
Transurethral Needle Ablation
Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
Stress Urinary Incontinence
Menorrhagia/Endometrial Ablation
Uterine Fibroids
Spinal Decompression and Denervation
Varicose Veins
Atrial Fibrillation
Tumor Ablation
Others

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Republic of South Africa
Rest of LAMEA
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AngioDynamics Inc
  • AtriCure Inc
  • BTG plc
  • Conmed Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • MORE
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 U.S. FDA
3.3.2 Europe CE mark
3.3.3 Others
3.4 Reimbursement scenarios
3.5 Clinical trials
3.6 Patent analysis
3.6.1 Patent analysis, by year
3.6.2 Patent analysis, by company
3.7 Top impacting factors
3.7.1 Drivers
3.7.1.1 Rise in the prevalence of chronic illnesses
3.7.1.2 Technological advancements
3.7.1.3 Short duration and high efficacy of the procedure
3.7.2 Restraints
3.7.2.1 Government regulations and reimbursement policies
3.7.2.2 High cost and limited awareness
3.7.3 Opportunities
3.7.3.1 Increase in the level of awareness
3.7.3.2 Untapped markets in emerging economies

CHAPTER 4 WORLD ABLATION DEVICES MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Thermal ablation technology
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Radiofrequency ablation
4.2.4.1 Market size and forecast
4.2.4.2 Temperature-controlled radiofrequency ablation devices
4.2.4.3 Market size and forecast
4.2.4.4 Fluid-cooled radiofrequency ablation
4.2.4.5 Market size and forecast
4.2.4.6 Catheter manipulation system
4.2.4.7 Market size and forecast
4.2.5 Electrical ablation
4.2.5.1 Market size and forecast
4.2.5.2 Electrical ablators
4.2.5.3 Market size and forecast
4.2.5.4 Argon plasma/beam coagulator
4.2.5.5 Market size and forecast
4.2.5.6 Irreversible electroporation
4.2.5.7 Market size and forecast
4.2.5.8 Electronic brachytherapy
4.2.5.9 Market size and forecast

4.2.6 Microwave
4.2.6.1 Market size and forecast
4.2.7 Hydrothermal ablation
4.2.7.1 Market size and forecast
4.2.8 Light ablation
4.2.8.1 Market size and forecast
4.2.8.2 Cold laser
4.2.8.3 Market size and forecast
4.2.8.4 Excimer laser
4.2.8.5 Market size and forecast
4.2.9 Radiation ablation
4.2.9.1 Market size and forecast
4.2.9.2 Brachytherapy
4.2.9.3 Market size and forecast
4.2.9.4 High-dose-rate brachytherapy
4.2.9.5 Market size and forecast
4.2.9.6 Pulsed-dose-rate brachytherapy
4.2.9.7 Market size and forecast
4.2.9.8 Permanent seed brachytherapy or low-dose-rate brachytherapy
4.2.9.9 Market size and forecast
4.2.9.10 Stereotactic radiotherapy and radiosurgery
4.2.9.11 Market size and forecast
4.2.9.12 Image-guided radiation therapy
4.2.9.13 Market size and forecast
4.2.9.14 Intensity-modulated radiation therapy
4.2.9.15 Market size and forecast
4.2.9.16 Stereotactic body radiation therapy
4.2.9.17 Market size and forecast
4.2.9.18 Proton beam therapy
4.2.9.19 Market size and forecast
4.2.10 Ultrasound ablation
4.2.10.1 Market size and forecast
4.2.10.2 High-intensity focused ultrasound
4.2.10.3 Market size and forecast
4.2.10.4 Magnetic resonance imaging guided focus ultrasound (MRI-FUS)
4.2.10.5 Market size and forecast
4.2.10.6 Ultrasonic surgical systems
4.2.10.7 Market size and forecast
4.2.10.8 Shock wave lithotripsy
4.2.10.9 Market size and forecast
4.3 Non-thermal ablation technology
4.3.1 Key market trends
4.3.2 Key growth opportunities and opportunities
4.3.3 Market size and forecast
4.3.4 Cryoablation
4.3.4.1 Market size and forecast
4.3.4.2 Tissue contact probe
4.3.4.3 Market size and forecast
4.3.4.4 Cryogen spray probe
4.3.4.5 Market size and forecast
4.3.4.6 Epidermal and subcutaneous cryoablation devices
4.3.4.7 Market size and forecast
4.3.5 Hydromechanical
4.3.5.1 Market size and forecast

CHAPTER 5 WORLD ABLATION DEVICES MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Cancer
5.2.1 Market size and forecast
5.3 Cardiovascular
5.3.1 Market size and forecast
5.4 Ophthalmology
5.4.1 Market size and forecast
5.5 Gynecology
5.5.1 Market size and forecast
5.6 Urology
5.6.1 Market size and forecast
5.7 Orthopedics
5.7.1 Market size and forecast
5.8 Others
5.8.1 Market size and forecast

CHAPTER 6 WORLD ABLATION DEVICES MARKET, BY FUNCTION
6.1 Overview
6.1.1 Market size and forecast
6.2 Automated/robotic ablation devices
6.2.1 Market size and forecast
6.3 Conventional ablation devices
6.3.1 Market size and forecast
CHAPTER 7 WORLD ABLATION DEVICES MARKET, BY PROCEDURE
7.1 Overview
7.1.1 Market size and forecast
7.2 Aesthetics-skin rejuvenation and tightening
7.2.1 Market size and forecast
7.3 Aesthetics-body sculpting, fat reduction, and the minimization in the appearance of cellulite
7.3.1 Market size and forecast
7.4 Benign prostatic hyperplasia
7.4.1 Market size and forecast
7.5 Transurethral needle ablation
7.5.1 Market size and forecast
7.6 Laser and other energy-based therapies/holmium laser ablation /enucleation of the prostate
7.6.1 Market size and forecast
7.7 Stress urinary incontinence
7.7.1 Market size and forecast
7.8 Menorrhagia/endometrial ablation
7.8.1 Market size and forecast
7.9 Uterine fibroids
7.9.1 Market size and forecast
7.10 Spinal decompression and denervation
7.10.1 Market size and forecast
7.11 Varicose veins
7.11.1 Market size and forecast
7.12 Atrial fibrillation
7.12.1 Market size and forecast
7.13 Tumor ablation
7.13.1 Market size and forecast
7.14 Others
7.14.1 Market size and forecast

CHAPTER 8 WORLD ABLATION DEVICES MARKET, BY GEOGRAPHY
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 U.S. market size and forecast
8.2.5 Canada market size and forecast
8.2.6 Mexico market size and forecast
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany market size and forecast
8.3.5 France market size and forecast
8.3.6 UK market size and forecast
8.3.7 Italy market size and forecast
8.3.8 Spain market size and forecast
8.3.9 Russia market size and forecast
8.3.10 Rest of Europe market size and forecast
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 Japan market size and forecast
8.4.5 China market size and forecast
8.4.6 Australia market size and forecast
8.4.7 India market size and forecast
8.4.8 South Korea market size and forecast
8.4.9 Taiwan market size and forecast
8.4.10 Rest of Asia-Pacific market size and forecast
8.5 Latin America, Middle East, And Africa (LAMEA)
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Brazil market size and forecast
8.5.5 Turkey market size and forecast
8.5.6 Venezuela market size and forecast
8.5.7 Saudi Arabia market size and forecast
8.5.8 Republic of South Africa market size and forecast
8.5.9 Rest of LAMEA market size and forecast

CHAPTER 9 COMPANY PROFILES
9.1 Medtronic PLC
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Business performance
9.1.5 Key strategic moves and developments
9.2 Johnson and Johnson
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Business performance
9.2.5 Key strategic moves and developments
9.3 St. Jude Medical, Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Business performance
9.3.5 Key strategic moves and developments
9.4 Boston Scientific Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Business performance
9.4.5 Key strategic moves and developments
9.5 AngioDynamics, Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Business performance
9.5.5 Key strategic moves and developments
9.6 AtriCure, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Business performance
9.6.5 Key strategic moves and developments
9.7 Conmed Corporation

9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Business performance
9.7.5 Key strategic moves and developments

9.8 Olympus Corporation

9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Business performance
9.8.5 Key strategic moves and developments

9.9 Smith & Nephew PLC

9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Business performance
9.9.5 Key strategic moves and developments

9.10 BTG plc

9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Business performance
9.10.5 Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AngioDynamics Inc
  • AtriCure Inc
  • BTG plc
  • Conmed Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • MORE
Ablation Devices Market by Technology (Thermal Ablation, Electrical, Radiation, Radiofrequency, Ultrasound, Microwave, Hydrothermal, Non-Thermal Ablation, Cryoablation) would reach $6,658 million by 2022 from $3,047 million in 2015, growing at a CAGR of 11.7% during the forecast period. Thermal ablation devices segment is estimated to dominate the market throughout the analysis period. About two-thirds of the world ablation devices market share was captured by cardiovascular and cancer segment in 2015.

Ablation is a minimally invasive procedure that treats various chronic diseases such as cancer and pulmonary conditions, as well as used for aesthetic procedures. The market is expected to grow at a significant rate due to various advantages of ablation procedures (short time duration, minimized blood loss and damage to healthy organs and tissues, operator friendly) over conventional methods such as chemotherapy, as it has high side-effects. The introduction of innovative and advanced ablation technologies and the increase in the prevalence of chronic diseases and awareness about the procedure would contribute towards the market growth. However, the market growth is hindered by unstable reimbursement policies, stringent government regulations, limited awareness, and high cost of the procedure.

Thermal segment dominated the world ablation devices market in 2015 and is expected to continuewith its dominance throughout the forecast period. This is attributed to the various applications of thermal ablation devices for cancer and cardiovascular surgeries. However, owing to the higher success rate and advantages, non-thermal technologies is estimated to be the fastest growing segment propelling at an estimated CAGR of 17.7%.

In the year 2015, cancer segment held the majority of the market share due to increase in the number of cancer patients and high precision of ablation techniques to destroy cancer cells. In addition, it is estimated to retain its market position throughout the forecast period, registering a CAGR of 11.4%. Cardiovascular is anticipated to be the fastest growing segment, as cardiac ablation provides site-specific treatment and prevents infection to the surrounding tissues.

With the robotic ablation devices, the procedure can be conducted with miniaturization, precision, and smaller incisions. Hence, it is expected to be the fastest growing function segment. However, this technique is relatively new and expensive as compared to the conventional methods. Therefore, currently conventional ablation devices is the dominant segment in the ablation device market.

By procedure, tumor ablation segment occupies the largest share in the ablation device market and is expected to maintain its lead throughout the analysis period. The number of cancer cases are increasing and it is one of the leading causes of morbidity and mortality in the world. For instance, in 2012, there were about 14 million new cases and 8.2 million cancer-related deaths.

Key findings of the Ablation Devices Market:

Varicose veins segment is estimated to exhibit a CAGR of 15.6%, among procedure types.
Cardiovascular is anticipated to be the fastest growing segment throughout the analysis period.
Epidermal and subcutaneous cryoablation devices are the fastest growing sub-markets from cryoablation devices segment.
Turkey ablation devices market is projected to grow at a CAGR of 10.8%.
Automated/robotic ablation devices market is projected to grow at a CAGR of 14.3%.
Presently, North America and Europe have the highest growth potential due to established reimbursement policies, high buying power, rapid adoption ofminimal-invasive therapies, rise in the count of aging population, and increasing prevalence of patients with chronic illnesses. However, the market would gain traction in the developing regions of Asia-Pacific and Latin America as well, due to the increase in urbanization & disposable income, large number of undiagnosed patients, and growing awareness about ablation devices.

The key players profiled in this report include Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., St. Jude Medical, Inc., Medtronic plc, Conmed Corporation, Olympus Corporation, Johnson & Johnson, Smith & Nephew plc, and BTG plc.
Note: Product cover images may vary from those shown
5 of 5
  • St Jude Medical Inc
  • Medtronic PLC
  • Boston Scientific Corporation
  • AngioDynamics Inc
  • AtriCure Inc
  • Conmed Corporation
  • Olympus Corporation
  • Smith & Nephew PLC
  • BTG plc
  • Johnson & Johnson
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll